vagus nerve stimulator
Neuromodulation Reduces Inflammation and Improves Outcomes in COVID-19 Patients
Evidence from a randomized controlled study suggests that nVNS reduces inflammation, severity of illness and ...
JUNE 16, 2022
From Pain Device to Approved Pandemic Treatment, nVNS System Improves Airflow in COVID-19 Patients
A noninvasive vagus nerve stimulation device previously indicated for acute and preventive migraine and cluster ...
NOVEMBER 5, 2020
Noninvasive VNS Shown Effective For Symptoms of Vestibular Migraine
Noninvasive vagus nerve stimulation provided rapid relief of vertigo and headache pain caused by acute vestibular ...
FEBRUARY 26, 2020
Neuromodulation Shown Potentially Safe, Effective for Rheumatoid Arthritis
A new bioelectronic medicine approach to treat autoimmune diseases using vagus nerve stimulation (VNS) demonstrated ...
APRIL 18, 2019
Noninvasive Vagus Nerve Stimulator Receives FDA Clearance for Adjunctive, Preventive Treatment of Adult Cluster Headache
The FDA granted 510(k) clearance for an expanded label for noninvasive vagus nerve stimulator (nVNS; gammaCore, ...
NOVEMBER 30, 2018
FDA Approves Noninvasive Vagus Nerve Stimulation Therapy for Acute Episodic Cluster Headache
The FDA released the use of the gammaCore noninvasive vagus nerve stimulator (electroCore) for the acute treatment ...
APRIL 19, 2017